Defining significance of the novel tGLI1 transcription factor in cancer growth and progression

被引:0
|
作者
Cao, Xinyu [1 ]
Dewhirst, Mark [1 ]
Ali-Osman, Francis [1 ]
Lo, Hui-Wen [1 ]
机构
[1] Duke Univ, Durham, NC USA
关键词
D O I
10.1158/1538-7445.AM2011-2337
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2337
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Truncated glioma-associated oncogene homolog 1 (tGLI1) is an actionable therapeutic target in breast cancer brain metastases.
    Doheny, Daniel L.
    Sirkisoon, Sherona R.
    Rimkus, Tadas
    Zhu, Dongqin
    Aguayo, Noah R.
    Anguelov, Marlyn
    Manore, Sara
    Xing, Fei
    Metheny-Barlow, Linda
    Watabe, Kounosuke
    Thomas, Alexandra
    Masters, Adrianna Henson
    Strowd, Roy E.
    Lo, Hui-Wen
    CANCER RESEARCH, 2021, 81 (13)
  • [22] Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis
    Daniel Doheny
    Sherona Sirkisoon
    Richard L. Carpenter
    Noah Reeve Aguayo
    Angelina T. Regua
    Marlyn Anguelov
    Sara G. Manore
    Austin Arrigo
    Sara Abu Jalboush
    Grace L. Wong
    Yang Yu
    Calvin J. Wagner
    Michael Chan
    Jimmy Ruiz
    Alexandra Thomas
    Roy Strowd
    Jiayuh Lin
    Hui-Wen Lo
    Oncogene, 2020, 39 : 6589 - 6605
  • [23] Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer
    Sherona R. Sirkisoon
    Richard L. Carpenter
    Tadas Rimkus
    Ashley Anderson
    Alexandria Harrison
    Allison M. Lange
    Guangxu Jin
    Kounosuke Watabe
    Hui-Wen Lo
    Oncogene, 2018, 37 : 2502 - 2514
  • [24] The involvement of the transcription factor Yin Yang 1 in cancer development and progression
    Castellano, Giancarlo
    Torrisi, Elena
    Ligresti, Giovanni
    Malaponte, Grazia
    Militello, Loredana
    Russo, Alessia E.
    McCubrey, James A.
    Canevari, Silvana
    Libra, Massimo
    CELL CYCLE, 2009, 8 (09) : 1367 - 1372
  • [25] Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer
    Sirkisoon, Sherona R.
    Carpenter, Richard L.
    Rimkus, Tadas
    Anderson, Ashley
    Harrison, Alexandria
    Lange, Allison M.
    Jin, Guangxu
    Watabe, Kounosuke
    Lo, Hui-Wen
    ONCOGENE, 2018, 37 (19) : 2502 - 2514
  • [26] STAT3 and GLI1/tGLI1 oncogenic transcription factors interact to promote the aggressiveness of triple-negative and HER2-enriched breast cancers
    Sirkisoon, Sherona R.
    Carpenter, Richard L.
    Tadas, Rimkus
    Ashley, Anderson
    Harrison, Alexandria
    Lange, Allison M.
    Jin, Guangxu
    Watabe, Kounosuke
    Lo, Hui-Wen
    CANCER RESEARCH, 2018, 78 (13)
  • [27] Defining ETS transcription regulatory networks and their contribution to breast cancer progression
    Turner, David P.
    Findlay, Victoria J.
    Moussa, Omar
    Watson, Dennis K.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 102 (03) : 549 - 559
  • [28] Exploring the role of transcription factor TWIST1 in bladder cancer progression
    EL Azzouzi, Meryem
    Addoum, Boutaina
    El Ahanidi, Hajar
    Hassan, Ilias
    Tetou, Mohammed
    Ameur, Ahmed
    Al Bouzidi, Abderrahmane
    Oukabli, Mohamed
    Benbacer, Laila
    Attaleb, Mohammed
    El Mzibri, Mohammed
    Chaoui, Imane
    CANCER GENETICS, 2025, 292 : 44 - 48
  • [29] Inactivation of the Transcription Factor GLI1 Accelerates Pancreatic Cancer Progression
    Mills, Lisa D.
    Zhang, Lizhi
    Marler, Ronald
    Svingen, Phyllis
    Fernandez-Barrena, Maite G.
    Dave, Maneesh
    Bamlet, William
    McWilliams, Robert R.
    Petersen, Gloria M.
    Faubion, William
    Fernandez-Zapico, Martin E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (23) : 16516 - 16525
  • [30] Overexpressed transcription factor FOXM1 contributes to the progression of colorectal cancer
    Zhang, Hongmei
    Zhong, Hua
    Li, Lei
    Ji, Wansheng
    Zhang, Xiaoqian
    MOLECULAR MEDICINE REPORTS, 2016, 13 (03) : 2696 - 2700